Consistent with these results, STAT3 was targeted predominantly in the tumor-promoting iCAF subpopulation defined by the Tuveson lab (Ohlund et al, 2017; Elyada et al, 2019), Interestingly, a portion of the tumor-proximal myCAFs were also targeted. The gene discussed is STAT3; the disease is neoplasm.